Literature DB >> 8055952

Identification of gastrin component I as gastrin-71. The largest possible bioactive progastrin product.

J F Rehfeld1, A H Johnsen.   

Abstract

Gastrin component I is the largest hormonally active form of gastrin. In order to determine its structure, we isolated progastrin-derived peptides from normal human antral tissue. A radioimmunoassay specific for sequence 20-25 of human progastrin was developed to monitor the purifications. After four or five steps of reverse-phase chromatography, the peptides were pure and could be identified by a combination of microsequence, amino acid and mass spectral analysis as well as by a library of sequence-specific immunoassays. In addition to intact progastrin 1-80, fragments 1-71, 1-35, 6-35, 20-35, and 20-36 of progastrin were identified. Only the 71-amino-acid peptide contained at its C-terminus the alpha-amidated bioactive site (Trp-Met-Asp-Phe-NH2). This unoheptacontapeptide amide (gastrin-71) corresponds to component I and is the largest possible bioactive product of progastrin. Its structure shows that progastrin is used in its entirety for biosynthesis of active peptides. The occurrence of fragments 6-35, 20-35, and 20-36 demonstrate that antral progastrin is partially cleaved at two monobasic sites (Arg5 and Arg19) in addition to processing at the three C-terminal dibasic sites. The results show that both the N- and C-terminal parts of antral progastrin undergo extensive processing. The results also suggest that progastrin may follow two different processing pathways of which the less trafficked releases gastrin-71.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055952     DOI: 10.1111/j.1432-1033.1994.tb19051.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  The G-cells in the dog: a light and electron microscope immunocytochemical study.

Authors:  J A Galán; F J Alonso; P Moratinos; J L González; B Fraile; M V Lobo
Journal:  Histochem J       Date:  1996-12

Review 2.  The endoproteolytic maturation of progastrin and procholecystokinin.

Authors:  Jens F Rehfeld
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

3.  Properties of the complex between recombinant human progastrin and ferric ions.

Authors:  Graham S Baldwin
Journal:  Protein J       Date:  2004-01       Impact factor: 2.371

Review 4.  Peptide processing and biology in human disease.

Authors:  Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

5.  Acute effects of N-terminal progastrin fragments on gastric acid secretion in man.

Authors:  Jens P Goetze; Carsten P Hansen; Jens F Rehfeld
Journal:  Physiol Rep       Date:  2017-03

Review 6.  Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy.

Authors:  Jens F Rehfeld
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-12-12

Review 7.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

8.  Post-poly(Glu) cleavage and degradation modified by O-sulfated tyrosine: a novel post-translational processing mechanism.

Authors:  J F Rehfeld; C P Hansen; A H Johnsen
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

Review 9.  The Physiology of the Gastric Parietal Cell.

Authors:  Amy C Engevik; Izumi Kaji; James R Goldenring
Journal:  Physiol Rev       Date:  2019-10-31       Impact factor: 37.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.